Sorafenib tosylate 475207-59-1

Chemical name: 4 - (4 - (3-4 - chloro - [3 - (three fluorinated methyl) phenyl] urea base} phenoxy) - n - 4-2 - carboxy methyl pyridine - amide toluene sulfonate

Molecular formula: C21H16ClF3N4O3 · C7H8O3S

Molecular weight: 637.0

usage

1. Treatment of inoperable advanced renal cell carcinoma.

2. Primary hepatocellular carcinoma that cannot be treated by surgery or metastasis.

Currently lack in patients with advanced hepatocellular carcinoma (HCC) sorafenib with interventional therapy such as hepatic artery embolism chemotherapy (conventional) randomized controlled clinical research data, the result is not clear this product relative to the pros and cons of interventional treatment, also can't clear to ever received interventional treatment for patients after the use of sorafenib is useful (see item "clinical trials"). Doctors are advised to select appropriate treatment methods according to the specific conditions of patients.